FIRM FIXED PRICENO SET ASIDE USED.
XLCARE PHARMACEUTICALS INC - NEW AWARD FOR LEVETIRACETAM TABLETS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD FEB 5, 2026 TO MAY 23, 2026, WITH FOUR ONE-YEAR OPTIONS.
PIID: 36E79726D0019Solicitation ID: 36E79726R0001
Signed Date: Feb 5, 2026Effective Date: May 24, 2026
Key Details
Description
NEW AWARD FOR LEVETIRACETAM TABLETS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD FEB 5, 2026 TO MAY 23, 2026, WITH FOUR ONE-YEAR OPTIONS.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.